Table 1.
Clinical characterization of the study population.
| Clinical Variable | N = 300 (150M:150F) |
|---|---|
| Age (Years) | 59.6 ± 0.8 |
| BMI (Kg/m2) | 27.1 ± 5.6 |
| Waist circumference (cm) | 97.2 ± 0.8 |
| SBP (mmHg) | 128.9 ± 0.9 |
| DBP (mmHG) | 84.4 ± 1.9 |
| Erythrocytes (106/µL) | 4.8 ± 0.1 |
| WBC (103/µL) | 6.3 ± 0.1 |
| Hemoglobin (g/dL) | 13.8 ± 0.1 |
| Neutrophils (%) | 59.2 ± 0.5 |
| Eosinophils (%) | 3.1 ± 0.3 |
| Basophils (%) | 0.6 ± 0.1 |
| Lymphocytes (%) | 30.7 ± 0.5 |
| Monocytes (%) | 6.4 ± 0.2 |
| Platelet count (10^6/μL) | 231.3 ± 3.6 |
| Total cholesterol (mg/dL) | 178.8 ± 2.4 |
| HDL-c (mg/dL) | 55.2 ± 1.1 |
| LDL-c (mg/dL) | 102.1 ± 2 |
| TG (mg/dL) | 117.6 ± 3.7 |
| Glucose (mg/dL) | 98.7 ± 1.6 |
| HbA1c (mmol/mol) | 39.9 ± 1 |
| 25-OH Vitamin D(ng/mL) | 22.6 ± 0.6 |
| Hs-CRP (mg/L) | 4.7 ± 0.5 |
| GGT (U/L) | 35.2 ± 1 |
| AST (U/L) | 20.9 ± 0.6 |
| ALT (U/L) | 28.3 ± 1 |
| ALP (U/L) | 63.9 ± 1.4 |
| CVR (Framingham) | 16.77 ± 1 |
| FLI | 50 ± 2 |
| VAI | 4.1 ± 0.2 |
| HSI | 33.6 ± 0.4 |
| NFS | −1 ± 0.1 |
| MED DIET SCORE | 32.2 ± 0.3 |
| MEDI-LITE SCORE | 12.8 ± 0.2 |
Data are presented as mean ± SEM (standard error of the mean). Abbreviations: body mass index, BMI; systolic blood pressure, SBP; white blood cells, WBC; high-density lipoprotein cholesterol, HDL-c; low-density lipoprotein cholesterol, LDL-c; triglycerides, TG; glycosylated hemoglobin, HbA1c; high-sensitivity C reactive protein Hs-CRP; gamma-glutamyltransferase, GGT; aspartate transaminase, AST; alanine transaminase, ALT; alkaline phosphatase, ALP; cardiovascular risk, CVR; Fatty Liver Index, FLI; Visceral Adiposity Index, VAI; Hepatic Steatosis Index, HIS; NAFLD Score, NFS.